You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Acquired Hemophilia A: Applying Current Evidence to Practice

  • Authors: Andreas Tiede, MD, PhD; Rebecca Kruse-Jarres, MD, MPH
  • CME Released: 11/18/2022
  • Valid for credit through: 11/18/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US emergency medicine physicians, hematology/oncology specialists, and critical care specialists.

The goal of this activity is for learners to be better able to control acute acquired hemophilia A (AHA) bleeding based on the latest evidence.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Latest clinical studies evaluating therapies to control acute AHA bleeding
  • Have greater competence related to
    • Selecting a treatment to control acute AHA bleeding based on the latest evidence


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships. 


Faculty

  • Andreas Tiede, MD, PhD

    Professor of Hematology and Oncology
    Hannover Medical School
    Hannover, Germany

    Disclosures

    Andreas Tiede, MD, PhD, has the following relevant financial relationships: 
    Consultant or advisor for: Bayer; BioMarin Pharmaceutical; Biotest; Boehringer Ingelheim; Chugai Pharmaceutical; CSL Behring; Daiichi Sankyo; Leo Pharma; Novo Nordisk; Octapharma; Pfizer, Inc.; Portola Pharmaceuticals; Roche; SOBI; Takeda Pharmaceutical Company
    Speaker or member of speakers bureau for: Bayer; BioMarin Pharmaceutical; Biotest; Boehringer Ingelheim; Chugai Pharmaceutical; CSL Behring; Daiichi Sankyo; Leo Pharma; Novo Nordisk; Octapharma; Pfizer, Inc.; Portola Pharmaceuticals; Roche; SOBI; Takeda Pharmaceutical Company
    Research funding from: Biotest; Chugai Pharmaceutical; CSL Behring; Novo Nordisk; Octapharma; Pfizer, Inc.; Roche; SOBI; Takeda Pharmaceutical Company
    Contracted researcher for: Novo Nordisk; Octapharma; Roche; SOBI; Takeda Pharmaceutical Company

  • Rebecca Kruse-Jarres, MD, MPH

    Professor of Medicine
    Division of Hematology
    University of Washington School of Medicine
    Director, Washington Center for Bleeding Disorders
    Seattle, Washington, United States

    Disclosures

    Rebecca Kruse-Jarres, MD, MPH, has the following relevant financial relationships:
    Consultant or advisor for: BioMarin; CSL Behring; CRISPR; Genentech; Pfizer, Inc.; Roche 
    Speaker or member of speakers bureau for: Genentech; Takeda Pharmaceutical Company

Editors

  • Keisha Peters, MSc

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Keisha Peters, MSc, has no relevant financial relationships.

  • Chii Shyang Fong, PhD

    Scientific Content Manager, WebMD Global, LLC

    Disclosures

    Chii Shyang Fong, PhD, has no relevant financial relationships.

Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

Acquired Hemophilia A: Applying Current Evidence to Practice

Authors: Andreas Tiede, MD, PhD; Rebecca Kruse-Jarres, MD, MPHFaculty and Disclosures

CME Released: 11/18/2022

Valid for credit through: 11/18/2023

processing....

Learning Feedback Questions

Please answer these questions to complement your learning experience.